3Sano H,KawahitoY,Wilder R L,et al.Expression of cyclooxygenase-1 and 2 in human colorectal cancer[J].Cancer Res,1995,55(17):3785-3789.
4Ohno R,Yoshinaga K,Magno R M,et al.Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma[J].Cancer,2001,91(10):1876-1881.
7Dong J T,Lamb P W,Rinker-Schaeffer C W,et al.KAI 1,ametastasissuppressorgene for prostate cancer on humar chromosome llpll.2.Science,1995,268(5212):884-886.
8Lombardi D P,Geradts J,Foley J F,et al.Loss of KAI 1 expression in the progression of coloreetal cancer[J].Cancer Res,1999,59(22):5724-5731.
9Shao J Y,Sheng H M,Inoue H,et al.Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells[J].J Biol Chem,2000,275(43):33951-33955.
10Sheng H M,Shao J Y,Dub Ois R N.K-Ras-mediated increase cyclooxygenase-2mRNA stability involves activation of the protein kinase B[J].Cancer Res,2001,61(6):2670-2675.
5Johnson ME , Howerth EW. Survivin : a bifunctional inhibitor of apoptosis protein [ J ]. Vet Pathol, 2004, 41 (6) : 599 - 607.
6Cho NP, Han HS, Soh Y, et al. Cytoplasmic HuR over- expression is associated with increased cyclooxygenase-2 expression in laryngeal squamous cell carcinomas [ J ]. Pathology, 2007, 39 (6) : 545 -550.
7Athanassiadou P, Grapsa D, Athanassiades P, et al. The prognostic significance of COX-2 and survivin expression in ovarian cancer[.1]. Pathot Res Pract, 2008, 204 (4) : 241 - 249.
8Nassar A, Lawson D, Cotsonis G, et al. Survivin and caspase-3 expression in breast cancer: correlation with prognostic parameters, proliferation, angiogenesis, and outcome [ J ]. Appl Immunohistochem Mol Morphol, 2008, 16 (2): 113-120.
9Li YH, Hu CF, Shao Q, et al. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma [ J ]. J Transl Med, 2008, 6: 1.
10Mehar A, Macanas-Pirard P, Mizokami A, et al. The effects of cyclooxygenase-2 expression in prostate cancer cells: modulation of response to cytotoxic agents [ J ]. J Pharmacol Exp Ther, 2008, 324(3) : 1181 - 1187.
